Navigation Links
Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference
Date:2/16/2011

PHOENIX, Feb. 16, 2011 /PRNewswire/ -- Spending on specialty medications is growing rapidly, but helping patients remain adherent to these important medications can help slow disease progression and keep patients out of the hospital, Prime Therapeutics Vice President of Specialty Pharmacy Solutions Elizabeth Mauer told participants at the 16th Annual Pharmacy Benefit Management Institute (PBMI) Drug Benefit Conference today.

"Balancing the tremendous financial burden of these drugs with their proven ability to improve health and save lives is a significant challenge for both members and plan sponsors," said Mauer. "Greater competition, new tools for specialty management, improved understanding of the cost/quality equation, a greater focus on patient outcomes and improved coordination across the health care spectrum will all change how we manage specialty benefits in the years ahead."

Specialty pharmaceuticals treat complex or chronic illnesses such as multiple sclerosis, hemophilia, hepatitis C and rheumatoid arthritis – conditions for which adherence to medications is critical. Many of these medications are "biologic" drugs, requiring a complex production process. Spending on specialty medications is increasing at twice the rate of the overall drug market, reaching an average annual cost of $32,735 in 2009.(i)

Mauer also spoke about the forces driving growth of specialty spending and identified the four keys for effective specialty pharmacy management: distribution channel, utilization management, care management and contracting activities.

"Through Prime's Triessent program, we found that safe and efficient delivery of medications, education and guidance from clinicians helps patients manage both their benefits and their condition," said Mauer. "Our integrated approach to pharmacy and medical care helps patients better adhere to their treatment plan. That means better health, fewer hospitalizations and less chance of needing additional treatments."

As a result of Triessent's approach, Prime has been able to help members achieve greater adherence rates than are typical without the program, while managing the cost of these medications for members and plan sponsors.

Delivered to an audience of pharmaceutical manufacturers, benefit managers and other experts within the industry, Mauer's discussion was one of the meeting's first day breakout sessions.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to nearly 17 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 12 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.

(i) Stephen W. Schondelmeyer, PRIME Institute, University of Minnesota, Leigh Purvis, AARP Public Policy Institute, and David J. Gross, AARP Office of Policy and Integration. "Rx Watchdog Report: Drug Prices Continue to Climb Despite Lack of Growth in General Inflation Rate." Insight on the Issues 36, November 2009. http://assets.aarp.org/rgcenter/ppi/health-care/i36-watchdog.pdf.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
2. Greenways PrimeSUITE EHR Featured at IHE North America Connectathon
3. Greenways PrimeSUITE Endorsed by Allina Hospitals & Clinics
4. Prime Healthcare Converts System-Wide to Masimo rainbow SET Technology
5. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
6. Prime Therapeutics Receives 2011 TIPPS Certification
7. Greenways PrimeSUITE Receives ONC-ATCB 2011/2012 Certification
8. Prime Therapeutics Announces URAC Accreditation
9. Prime Therapeutics Hires Peter Wickersham, Senior Vice President Cost of Care
10. Massachusetts Regional Extension Center Selects Greenways PrimeSuite
11. Nigerian Association of Pharmacists and Pharmaceutical Scientists in America (NAPPSA) Announces Prime Vendor Agreement with H. D. Smith
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
Breaking Medicine News(10 mins):